These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 14973309)

  • 21. Pharmacokinetics and safety of Fosfluconazole after single intravenous bolus injection in healthy male Japanese volunteers.
    Sobue S; Sekiguchi K; Shimatani K; Tan K
    J Clin Pharmacol; 2004 Mar; 44(3):284-92. PubMed ID: 14973307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conversion of viramidine to ribavirin in vivo by adenosine deaminase and its inhibition by 2'-deoxycoformycin.
    Wu JZ; Yeh LT; Lin CC; Hong Z
    Antivir Chem Chemother; 2006; 17(1):33-9. PubMed ID: 16542004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety, tolerability, pharmacokinetics, and pharmacodynamic properties of taranabant, a novel selective cannabinoid-1 receptor inverse agonist, for the treatment of obesity: results from a double-blind, placebo-controlled, single oral dose study in healthy volunteers.
    Addy C; Li S; Agrawal N; Stone J; Majumdar A; Zhong L; Li H; Yuan J; Maes A; Rothenberg P; Cote J; Rosko K; Cummings C; Warrington S; Boyce M; Gottesdiener K; Stoch A; Wagner J
    J Clin Pharmacol; 2008 Apr; 48(4):418-27. PubMed ID: 18258750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoid receptor agonist 13, a novel cannabinoid agonist: first in human pharmacokinetics and safety.
    Gardin A; Kucher K; Kiese B; Appel-Dingemanse S
    Drug Metab Dispos; 2009 Apr; 37(4):827-33. PubMed ID: 19144772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of pradefovir and PMEA in healthy volunteers after oral dosing of pradefovir.
    Lin CC; Xu C; Teng A; Yeh LT; Peterson J
    J Clin Pharmacol; 2005 Nov; 45(11):1250-8. PubMed ID: 16239358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone.
    Jaakkola T; Backman JT; Neuvonen M; Neuvonen PJ
    Clin Pharmacol Ther; 2005 May; 77(5):404-14. PubMed ID: 15900286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relative bioavailability of tizanidine hydrochloride capsule formulation compared with capsule contents administered in applesauce: a single-dose, open-label, randomized, two-way, crossover study in fasted healthy adult subjects.
    Henney HR; Fitzpatrick A; Stewart J; Runyan JD
    Clin Ther; 2008 Dec; 30(12):2263-71. PubMed ID: 19167586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
    Zhao RK; Cheng G; Tang J; Song J; Peng WX
    Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of ribavirin, levovirin and viramidine on liver toxicological gene expression in rats.
    Fang C; Srivastava P; Lin CC
    J Appl Toxicol; 2003; 23(6):453-9. PubMed ID: 14635270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of the new antiepileptic and CNS drug RWJ-333369 following single and multiple dosing to humans.
    Yao C; Doose DR; Novak G; Bialer M
    Epilepsia; 2006 Nov; 47(11):1822-9. PubMed ID: 17116021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of clinically relevant pharmacokinetic interaction between ribavirin and tenofovir in healthy subjects.
    Ramanathan S; Cheng A; Mittan A; Ebrahimi R; Kearney BP
    J Clin Pharmacol; 2006 May; 46(5):559-66. PubMed ID: 16638739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Pharmacokinetics and Safety of ALZ-801, a Novel Prodrug of Tramiprosate in Development for the Treatment of Alzheimer's Disease.
    Hey JA; Yu JY; Versavel M; Abushakra S; Kocis P; Power A; Kaplan PL; Amedio J; Tolar M
    Clin Pharmacokinet; 2018 Mar; 57(3):315-333. PubMed ID: 29063518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers.
    Boonleang J; Panrat K; Tantana C; Krittathanmakul S; Jintapakorn W
    Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study Team.
    Aweeka FT; Kang M; Yu JY; Lizak P; Alston B; Chung RT;
    HIV Med; 2007 Jul; 8(5):288-94. PubMed ID: 17561874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects.
    Kim SD; Kang W; Lee HW; Park DJ; Ahn JH; Kim MJ; Kim EY; Kim SW; Nam HS; Na HJ; Yoon YR
    Clin Ther; 2009 Apr; 31(4):793-803. PubMed ID: 19446152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy-associated hypercalcemia.
    Usui T; Oiso Y; Tomita A; Ogata E; Uchida T; Ikeda K; Watanabe T; Higuchi S
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):239-44. PubMed ID: 9208339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of oltipraz and its major metabolite (RM) in patients with liver fibrosis or cirrhosis: relationship with suppression of circulating TGF-beta1.
    Kim SG; Kim YM; Choi YH; Lee MG; Choi JY; Han JY; Cho SH; Jang JW; Um SH; Chon CY; Lee DH; Jang JJ; Yu ES; Lee YS
    Clin Pharmacol Ther; 2010 Sep; 88(3):360-8. PubMed ID: 20664537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and safety of single-dose ribavirin in patients with chronic renal impairment.
    Gupta SK; Kantesaria B; Glue P
    Drug Discov Ther; 2013 Aug; 7(4):158-63. PubMed ID: 24071578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical pharmacokinetics of alamifovir and its metabolites.
    Chan C; Abu-Raddad E; Golor G; Watanabe H; Sasaki A; Yeo KP; Soon D; Sinha VP; Flanagan SD; He MM; Wise SD
    Antimicrob Agents Chemother; 2005 May; 49(5):1813-22. PubMed ID: 15855501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.